Back to Search
MARIA RIOFRIO, MD
MD
Internal Medicine Physician
NPI: 1316797244Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
125084885(IL)
Research & Publications (6)
A phase II study of Yondelis (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer.
PMID 16736024·Br J Cancer·2006
3-trial
Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients.
PMID 14990645·J Clin Oncol·2004
3-trial
Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
PMID 11745280·Cancer·2001
3-trial
Single-agent estramustine phosphate (EMP) is active in advanced breast cancer after failure with anthracyclines and taxanes.
PMID 11697838·Ann Oncol·2001
3-trial
Phase I and pharmacokinetic study of ecteinascidin-743, a new marine compound, administered as a 24-hour continuous infusion in patients with solid tumors.
PMID 11230466·J Clin Oncol·2001
3-trial
Ecteinascidin-743: a marine-derived compound in advanced, pretreated sarcoma patients--preliminary evidence of activity.
PMID 11230465·J Clin Oncol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3134 N CLARK ST
CHICAGO, IL 60657 - Phone
- (312) 766-4949
Quick Facts
- NPI
- 1316797244
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile